Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01889 (
ankylosing spondylitis
)
5,717
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
LILR and KIR receptors recognize HLA-B27 and may influence immune response in
ankylosing spondylitis
(AS) development. Purpose of the study was to analyse LILRB1/
LILRA3
polymorphisms in AS. We observed a possible protective effect of the T allele of LILRB1 rs1061680:T>C and no association with insertion/deletion polymorphisms of
LILRA3
with AS.
...
PMID:The effect of LILRB1 but not LILRA3 gene polymorphism in immunopathology of ankylosing spondylitis-A parallel to KIR genes. 3089 32
Introduction:
Leukocyte immunoglobulin-like receptor A3 (
LILRA3
) belongs to the LILR family with unique feature of a 6.7-kb deletion variation among individuals. Frequencies of the 6.7-kb deletion vary widely across populations, but so far it has not been carefully investigated among Han Chinese subpopulations. Furthermore, we previously identified the non-deleted (functional)
LILRA3
as a novel genetic risk for multiple autoimmune diseases. The current study aimed to investigate (i) whether frequencies of the
LILRA3
6.7-kb deletion differ within Han Chinese subpopulations and (ii) whether the functional
LILRA3
is a novel genetic risk for
ankylosing spondylitis
(AS).
Methods:
The
LILRA3
6.7-kb deletion was genotyped in two independent cohorts, including 1,567 subjects from Shenzhen Hospital and 2,507 subjects from People's Hospital of Peking University. Frequencies of the 6.7-kb deletion were first investigated in combined healthy cohort according to the Chinese administrative district divisions. Association analyses were performed on whole dataset and subsets according to the geographic regions. Impact of the functional
LILRA3
on AS disease activity was evaluated.
Results:
Frequencies of
LILRA3
6.7-kb deletion were highly differentiated within Han Chinese subpopulations, being gradually decreased from Northeast (80.6%) to South (47.4%). Functional
LILRA3
seemed to be a strong genetic risk in susceptibility to AS under almost all the alternative genetic models, if the study subjects were not geographically stratified. However, stratification analysis revealed that the functional
LILRA3
was consistently associated with AS susceptibility mainly in Northern Han subgroup under the alternative genetic models, but not in Central and Southern Hans. Functional
LILRA3
conferred an increased disease activity in AS patients (
P
< 0.0001 both for CRP and ESR, and
P
= 0.003 for BASDAI).
Conclusions:
The present study is the first to report that the frequencies of
LILRA3
6.7-kb deletion vary among Chinese Hans across geographic regions. The functional
LILRA3
is associated with AS susceptibility mainly in Northern Han, but not in Central and Southern Han subgroups. Our finding provides new evidence that
LILRA3
is a common genetic risk for multiple autoimmune diseases and highlights the genetic differentiation among different ethnicities, even within the subpopulations of an ethnic group.
...
PMID:Frequencies of the
LILRA3
6.7-kb Deletion Are Highly Differentiated Among Han Chinese Subpopulations and Involved in Ankylosing Spondylitis Predisposition. 3162 Jan 71